VOLUME 23 | NUMBER 9 | SEPTEMBER 2017 nature medicine r e s o u r c e MDD is a chronic debilitating illness affecting yearly 350 million people worldwide and inducing major economic and medical burdens on societies 1 . While it affects both males and females, MDD is characterized by a strong sexual dimorphism: females are 2-3 times more likely to develop MDD 2 and exhibit greater symptom severity, greater functional impairment, more atypical depressive symptoms and higher rates of comorbid anxiety 3,4 . Furthermore, males and females with MDD respond differently to antidepressant treatment 5, 6 .
r e s o u r c e MDD is a chronic debilitating illness affecting yearly 350 million people worldwide and inducing major economic and medical burdens on societies 1 . While it affects both males and females, MDD is characterized by a strong sexual dimorphism: females are 2-3 times more likely to develop MDD 2 and exhibit greater symptom severity, greater functional impairment, more atypical depressive symptoms and higher rates of comorbid anxiety 3, 4 . Furthermore, males and females with MDD respond differently to antidepressant treatment 5, 6 .
Functionally, males and females with MDD exhibit different magnitude, laterality and direction of volumetric changes observed across the brain 7, 8 . Differences in serotonin synthesis and in the density of the serotonin 5HT1A autoreceptor have also been reported between males and females with MDD [9] [10] [11] . In addition, activation of several components of the hypothalamic-pituitary-adrenal axis differs in males and females with MDD following stress 12 . Depressed women exhibit higher cortisol levels 13 and higher corticotropin-releasing factor sensitivity 14, 15 than their male counterparts. While these features define sex differences in MDD, the underlying molecular mechanisms remain largely unknown. Indeed, there have been few genome-wide characterizations and comprehensive comparisons of the transcriptional signatures defining MDD in males and females across the brain 16 . Global analyses of the male transcriptome in MDD have revealed alterations in genes related to the glutamatergic, GABAergic, serotonergic and polyaminergic systems across several cortical and subcortical brain regions [17] [18] [19] , lipid metabolism, immune response, ATP synthesis, regulation of transcription and translation, fibroblast growth factor signaling and cell proliferation [20] [21] [22] [23] in cortical regions, regulation of the hypothalamic-pituitary-adrenal axis in hypothalamus 24 and control of circadian rhythms in cortical and subcortical structures 25 . Many fewer studies have assessed female transcriptional regulation in MDD. With few exceptions 26, 27 , most of these studies adopted candidate gene approaches. They showed alterations in brain-derived neurotrophic factor (BDNF), GABAergic, somatostatin (SST), cholinergic, serotonergic and glutamatergic systems, as well as mitochondrial, energy metabolism and circadian rhythms in cortical and limbic regions [28] [29] [30] [31] [32] [33] [34] . Importantly, these findings have been complemented by transcriptional studies performed in various mouse models of stress. Although still focused predominantly on males, r e s o u r c e nature medicine VOLUME 23 | NUMBER 9 | SEPTEMBER 2017 1 1 0 3 these studies have yielded insights into the mechanisms underlying the effects of chronic social defeat stress, chronic variable stress (CVS) or social isolation across several brain regions 27, [35] [36] [37] [38] [39] . With the still limited success of genome-wide association studies (GWAS) at identifying genes associated with MDD in the general population 40, 41 , systems-based approaches are emerging as additional tools for revealing pathogenic etiologies for complex neuropsychiatric syndromes. Combined with conventional differential gene expression analyses, network-based approaches offer a data-driven, molecular classification scheme for MDD while revealing previously unappreciated subtypes of this heterogeneous syndrome. While these approaches have provided insights into different psychiatric conditions [42] [43] [44] [45] , they have not yet been used to characterize the sexual dimorphism of MDD across different brain regions.
RESULTS
Differential gene expression analysis reveals brain-region-and sex-specific transcriptional profiles in MDD We used RNA-seq to examine the transcriptome of six brain regions of humans with MDD and matched control subjects (Supplementary Table 1 ): ventromedial prefrontal cortex (vmPFC; also known as subgenual PFC; Brodmann area (BA) 25), orbitofrontal cortex (OFC; BA11), dorsolateral PFC (dlPFC; BA8/9), anterior insula (aINS), nucleus accumbens (NAc) and ventral subiculum (vSUB). For each brain region, we examined 26 MDD postmortem samples (13 males; 13 females) and 22 controls (13 males; 9 females). We found significant transcriptional changes across every brain region in males and females with MDD compared to control subjects (Supplementary  Tables 2 and 3) . Besides a significant effect of phenotype (principal component (PC) 4, P < 0.01), sex (PC3, P < 1.0 × 10 −4 ) and brain region (PC1, P < 5.0 × 10 −36 ), our analysis revealed a significant effect of RNA integrity (PC1, P < 1.0 × 10 −3 ), age (PC2, P < 0.01) and alcohol abuse (PC2, P < 0.05) on total variance. All of these factors were included in our statistical model as covariates. Furthermore, given the well-known impact of antidepressant treatment on gene expression 46 , medication status was also accounted for in our analysis. Other covariates-drug abuse, cause of death, history of child abuse and toxicology-were not significantly associated with global variation in gene expression.
We validated our RNA-seq findings on a subset of genes: 80% (16 out of 20) and 100% (20 out of 20) of genes differentially expressed by RNA-seq in male or female vmPFC, respectively, also showed altered expression by NanoString analysis of RNA samples from the same brains (Supplementary Table 4 ). In addition, 85% of genes (17 out of 20) identified in males in the first cohort were also differentially expressed in a second, independent validation cohort of males with MDD (male MDD: n = 15; male CTRL: n = 17). Similarly, 75% of genes (15 out of 20) identified in females in the first cohort were also differentially expressed in a third, independent cohort of females with MDD (female MDD: n = 6; female CTRL: n = 12). Sociodemographic and clinical information for these cohorts (composed of samples from two geographically distant brain banks) are listed in Supplementary  Tables 5 and 6 .
We next used an unbiased rank-rank hypergeometric overlap (RRHO) analysis to highlight shared transcriptional changes across brain regions in males and females with MDD. In males, RRHO revealed coordinated up-and downregulation of transcriptional signatures in dlPFC, OFC and vmPFC (maximum Fisher's exact test (FET) P < 1.0 × 10 −1,487 , Fig. 1a ) and a similar, but weaker, signal for downregulated genes between the aINS and vmPFC, OFC, dlPFC and NAc (Fig. 1a) . While similar, albeit weaker, overlapping patterns were found across cortical regions in female MDD, our analysis highlighted a coordinated up-and downregulation of genes across vSUB and most cortical regions but not NAc (Fig. 1b) . The overlap between aINS and the cortical regions was also stronger in females than males with MDD (Fig. 1b) . FETs restricted to the subsets of differentially expressed genes (DEGs) across brain regions confirmed these regional overlaps in both males and females with MDD ( Supplementary  Fig. 1a,b and Supplementary Tables 7 and 8 for full statistics and lists of overlapping genes).
We found little overlap between male and female MDD transcriptional patterns in any brain region analyzed, with the exception of the NAc (Fig. 1c) . Furthermore, a direct comparison restricted to only DEGs in males versus females with MDD revealed just 5-10% overlap ( Fig. 1d and Supplementary Table 9 ) across all six brain regions. We found a similar lack of male-female overlap in three more brain regions-middle frontal area or BA46, striatum and whole hippocampus-from a publicly available MDD microarray data set (GEO, GSE53987; Supplementary Fig. 2 and Supplementary Table 9) . Likewise, the directionality of the changes observed in males and females with MDD was different (Fig. 1e) . Gene ontology analysis revealed several pathways enriched for DEGs in males or females with MDD across every brain region and, despite the small overlap in male and female DEGs, several of the same molecular pathways were implicated in both (Supplementary Table 10 ). Further analyses indicated that the small overlap observed between DEGs in males and females with MDD is not due to baseline sex differences in gene expression (Supplementary Tables 11 and 12 ).
Network analyses identify sex-specific transcriptional signatures associated with MDD To better resolve sex-specific transcriptional signatures in brain and gain insight into the molecular mechanisms involved in MDD, we constructed male and female multi-brain-region coexpression networks that combined all six brain regions studied. Our analysis identified numerous male and female transcriptional modules, each named by an arbitrary color. We deduced 143 modules in males with MDD and 158 in control males, each comprising between 10 and 6,687 genes. Likewise, our analysis uncovered 167 female MDD and 127 female control modules, each ranging from 10 to 10,395 genes.
We next used module differential connectivity (MDC) analysis to quantify changes in network connectivity between MDD and control conditions in both males and females ( Supplementary Fig. 3a,b) . MDC is the ratio of the average connectivity for any pair of genes within MDD modules compared to the same gene pairs in control modules 44 and as such informs on the structural reorganization of transcriptional profiles taking place between any two conditions (i.e., MDD versus controls, males versus females). The distribution of male and female MDC scores for MDD modules highlights several modules with a gain of connectivity (GOC), while only a small subset of male modules show a loss of connectivity (LOC) (Supplementary Fig. 3b ). Several biological processes were associated with male and female MDD modules that exhibited a GOC or LOC ( Supplementary Fig. 3c and Supplementary  Tables 13 and 14) . While several of these functions have previously been associated with MDD, our analysis provides new evidence that certain functions are affected in a sex-specific fashion.
We directly compared the sex-specific transcriptional organization of gene modules by measuring the homology between modules in males and females with MDD. Supplementary Figure 3d displays the modules in males and females with MDD sharing high levels of r e s o u r c e homology at the gene membership and functional levels (FET corrected P < 0.05; fold enrichment > 15). Interestingly, of the 55 male MDD modules conserved in female MDD, only 10 showed conserved connectivity with their female MDD homologs, while the remaining 45 male MDD modules gained connectivity compared to their female MDD homologs. Supplementary Figure 3e displays the biological processes shared by males and females with MDD and characterized by a GOC. Together, these findings suggest that, even for modules conserved on a gene membership level, only a small subset of them display conserved connectivity between males and females with MDD. This disparity between males and females was further confirmed by our module preservation analysis, which showed that only 31% of the male MDD modules and 26% of the female MDD modules were preserved in the opposite sex (Supplementary Tables 15 and 16 ).
Consistent with previous network-based comparisons [42] [43] [44] [45] , we identified several MDD-associated modules in males and females that were enriched for genes expressed predominantly in specific cell types, such as neurons, microglia, oligodendrocytes, astrocytes or endothelial cells (Supplementary Fig. 4a,b) . The results illustrate the association of MDD with transcriptional alterations occurring within several cell types, which appear to be affected differently in males and females. Indeed, our analysis showed that modules associated with a GOC in males with MDD were enriched for genes expressed in several cell types (Supplementary Fig. 4a ), whereas in female MDD, GOC modules were enriched mainly for neuronal genes ( Supplementary  Fig. 4b) . Notably, female MDD modules enriched for non-neuronal cell types showed conserved connectivity with control conditions (Supplementary Fig. 4b) . Overlapping DEGs with network analyses identifies sex-specific hub genes We next assessed the degree of enrichment for DEGs in male and female MDD modules ( Fig. 2a-d) . In total, we identified 77 modules in male MDD and 107 in female MDD enriched for DEGs in at least one brain region (FDR < 0.1). Modules were ranked on the basis of a composite measure considering the degree of enrichment for DEGs across brain regions and MDC against control conditions. This measure allows prioritization of modules for greater disruption in MDD (Fig. 2c,d) . In male MDD, the most highly ranked modules were associated with transmission of nerve impulse, organic acid metabolism, nerve ensheathment and regulation of catecholamine metabolism (Supplementary Table 13 ), whereas the most highly ranked female MDD modules were associated with nerve ensheathment, mitogen-activated protein kinase (MAPK) activity, inflammatory response and synaptic transmission (Supplementary Table 14) .
While some of these terms were seen in both male and female models (for example, nerve ensheathment), our analysis showed that both the patterns of MDC (Supplementary Fig. 3d ,e) and DEG enrichment differed between males and females with MDD. We used ARACNE (Algorithm for the Reconstruction of Accurate Cellular Networks) to display the structure of individual male and female MDD modules and to identify hub genes within these modules, and focused on two of the highest ranked modules associated with female or male MDD (Fig. 2e,f) . Hub genes are highly connected with neighboring genes within a given module and have been shown to be significantly associated with disease traits in other experimental systems 47, 48 . The female MDD-specific Gray26 module is enriched for MAPK activity and is composed of 18 genes, of which 4 are hubs. Gray26 has a marginal GOC compared to male MDD (MDC = 2.66; FDR = 0.3) but is highly enriched for genes downregulated in female MDD across every brain region examined (aINS: FDR = 4.32 × 10 −28 , Ch oc ola te Gra y17 (Fig. 2c,e) . In contrast, the male-specific Peru module, which is enriched in genes associated with synaptic transmission, is composed of 311 genes, of which 43 are hubs. Peru in male MDD has a GOC (MDC = 2.54, FDR < 0.01) compared to female MDD and is significantly enriched for genes upregulated, most strikingly, in vmPFC (FDR = 5.68 × 10 −79 ) and, to a lesser extent, in vSUB (FDR = 1.29 × 10 −15 ) and aINS (FDR = 7.63 × 10 −5 ), and downregulated in NAc (FDR = 9.82 × 10 −5 ; Fig. 2d,f) .
Sex-specific transcriptional responses are recapitulated in mice after CVS We next assessed whether similar sex differences in transcriptional profiles are produced in mice. We found that 21 d of CVS induced a range of depression-and anxiety-related behavioral abnormalities to an equivalent degree in male versus female mice (Fig. 3a-d) . These included increased latency to eat in the novelty-suppressed feeding test (F (1,40) = 24.3, P < 0.0001; Fig. 3a) , decreased time spent grooming in the splash test (F (1,40) = 8.68, P < 0.01; Fig. 3b ), a trend for increased time spent immobile in the forced swim test (F (1,40) = 3.61, P = 0.06; Fig. 3c ) and decreased sucrose preference (F (1,40) = 10.04, P < 0.005; Fig. 3d ). We used RNA-seq to survey the transcriptome from 20 males and 20 females (half stressed, half unstressed controls) after CVS, focusing on two representative brain regions implicated in stress responses in rodent models 49 : vmPFC and NAc. Our analysis revealed sex-specific changes in gene expression between stressed and unstressed mice across both brain regions (Supplementary Tables 17  and 18 ). DEGs were found to be expressed across several different cell types (neurons, astrocytes, oligodendrocytes, microglia and endothelial cells). However, we found a larger proportion of astrocyte and neuronal genes being significantly downregulated in female vmPFC and male NAc, as well as astrocytic and endothelial genes being significantly downregulated in male vmPFC (Supplementary Fig. 5 ).
Direct comparison of male versus female transcriptional profiles in the NAc by RRHO revealed an absence of overlap between stressed males and females (Fig. 3e) . While genes up-or downregulated in the vmPFC displayed some overlap between the sexes (Fig. 3e) , there was nevertheless a relatively small degree of overlap between DEGs in stressed males versus females, with ~25% of DEGs being shared in the vmPFC and ~20% in the NAc (Fig. 3e and Supplementary Table 9 ). The observation that the same repeated stress, which induces equivalent behavioral impairments in the two sexes, only induces 20-25% of the same gene expression changes in genetically identical male and female mice underscores the main finding of this study: namely, profound sex differences in transcriptional responses in brain to chronic stress.
Next we compared transcriptional profiles in the vmPFC and NAc between human MDD and mouse CVS cohorts using a combinatorial bioinformatic approach. We first identified genes that are up-or downregulated in the vmPFC or NAc in both depressed humans and stressed mice. In males, depressed humans and stressed mice shared 62 upregulated DEGs (fold change (FC): 1.2; corrected P = 0.32) and 90 downregulated DEGs (FC: 1.1; corrected P = 0.58) in vmPFC and 109 upregulated DEGs (FC: 3.1; corrected P = 9.29 × 10 −26 ) and 44 downregulated DEGs (FC: 3.7; corrected P = 1.49 × 10 −14 ) in NAc (Supplementary Table 19 ). Similarly, depressed human females and stressed female mice shared 128 upregulated DEGs (FC: 2.3; corrected P = 1.07 × 10 −18 ) and 123 downregulated DEGs (FC: 5.6; corrected P = 3.9 × 10 −59 ) in vmPFC and 89 upregulated DEGs (FC: 1.5; corrected P = 1.97 × 10 −4 ) and 81 downregulated DEGs (FC: 2.1; corrected P = 3.03 × 10 −10 ) in NAc (Supplementary Table 19 ). A gene ontology overlap analysis identified several pathways in the vmPFC and NAc conserved across species in males or females (Supplementary Tables 20 and 21) that may be involved in common in stress-induced pathology in the two species.
In vivo manipulation of male and female gene networks induces sex-specific behavioral alterations in mice We validated our bioinformatics predictions by focusing on two genes, DUSP6 and EMX1, neither of which has previously been implicated in MDD or stress responses. DUSP6 encodes dual-specificity phosphatase-6, which mediates several brain-related functions through inactivation of the ERK pathway 50 . It is a highly connected hub gene within the female-specific Gray26 module and is downregulated in vmPFC in female subjects with MDD and in stressed female mice (Fig. 2e) . Likewise, EMX1 encodes a transcription factor involved in the specification of neurons in the developing cortex 51 . It is a highly connected hub gene within the male-specific Peru module and is upregulated in the vmPFC in male subjects with MDD, in both our RNA-seq and replication cohorts (Fig. 2f) . We generated herpes simplex virus (HSV) vectors to downregulate Dusp6 expression by RNA interference, as well as a vector to overexpress mouse Emx1, and injected them into the mouse vmPFC before subthreshold CVS. We used subthreshold exposures to CVS (6 d males, 3 d females) that alone are insufficient to induce behavioral abnormalities in male or female mice, but can reveal enhanced stress susceptibility in response to specific manipulations 39 . Dusp6 downregulation (t (1,7) = 3.31, P < 0.05; Fig. 4a ,b) in the female vmPFC followed by 3 d of CVS increased significantly the latency to eat in the novelty-suppressed feeding test (F (1,25) = 13.26; P < 0.005; Fig. 4c ) as compared to unstressed controls infected with a GFP control construct (P < 0.01) and to Dusp6 unstressed controls (P < 0.005), and produced a strong trend toward significance compared to GFP stressed mice (P = 0.053). Dusp6 downregulation also significantly decreased sucrose preference (F (1,14) = 7.07; P < 0.05; Fig. 4e ) compared to Dusp6 unstressed controls (P < 0.05), with a trend toward decreased preference compared to GFP unstressed controls (P = 0.076) but not compared to GFP stressed mice. However, downregulation of Dusp6 in female vmPFC had no effect in the forced swim test, open field or elevated plus maze (data not shown). In contrast, equivalent Dusp6 downregulation in male vmPFC failed to induce stress susceptibility in both the novelty-suppressed feeding and sucrose preference tests (Fig. 4d,f) , supporting the sex-specific role of Dusp6 in controlling stress responses. Conversely, overexpression of Emx1 (t (1,5) = 2.40, P < 0.05; Fig. 4j ) in the male vmPFC followed by 6 d of stress increased the latency to initiate eating in the noveltysuppressed feeding test (F (1,33) = 11.00, P < 0.005; Fig. 4k ) compared to GFP unstressed controls (P < 0.05) and Emx1 unstressed controls (P < 0.05) but not GFP stressed mice. In contrast, equivalent Emx1 overexpression in the female vmPFC failed to induce stress susceptibility ( Fig. 4l) , supporting the sex-specific role of Emx1 in controlling stress responses.
Finally, we tested whether Dusp6 overexpression in vmPFC of female mice could rescue the effect of CVS. We generated an HSV vector to overexpress mouse Dusp6 and injected it into the vmPFC of female mice subjected to 6 d of CVS (Fig. 4g) . Dusp6 overexpression in female vmPFC (t (1,6) = 2.83, P < 0.05; Fig. 4g ) blocked the expression of the stress phenotype as measured with noveltysuppressed feeding (F (1,34) = 19.35, P < 0.0001; Fig. 4h ) and sucrose preference (F (1,31) = 5.56, P < 0.05; Fig. 4i ) compared to stressed mice expressing GFP alone.
Defining the molecular mechanisms underlying the sex-specific effect of Dusp6 in female mice Dusp6 has previously been shown to produce its effects through the dephosphorylation of ERK1/2 (ref. 50) . Consistent with the downregulation of Dusp6 found in the vmPFC of chronically stressed female mice, we found a significant increase in phospho-ERK1/2 (pERK) Significance in b, g and j was assessed using independent-sample t-test (two-sided). Significance in tests c-f, h, i, k and l was determined using two-way ANOVA with two-sided Tukey correction. Scatter plots depict value of each animal and bars represent the group average ± s.e.m.; *P < 0.05. n-values are given in the Online Methods.
r e s o u r c e levels in this region of stressed female mice compared to controls (t (1,19) = 2.33, P < 0.05; Fig. 5a ,e and Supplementary Fig. 6 ), but no difference in males. This effect was not associated with a change in total ERK1/2 levels ( Fig. 5b,e and Supplementary Fig. 6 ). Our analysis revealed very similar findings in humans with MDD. pERK was increased in females with MDD compared to healthy controls (t (1,27) = 1.92; P < 0.05; Fig. 5c ,f and Supplementary Fig. 7) , with no difference seen in males. No difference was found in total ERK1/2 levels in females or males with MDD ( Fig. 5d,f and Supplementary Fig. 7 ). Immunohistochemistry (IHC) revealed elevated pERK levels in the vmPFC of stressed (21 d of CVS) compared to unstressed female mice (t (1,11) = 2.39, P < 0.05; Fig. 5g ,h), with no effect seen in males. IHC of human postmortem tissue also confirmed elevated pERK in the PFC of females with MDD (t (1,12) = 2.96, P < 0.05; Fig. 5i-l) . This effect was not specific to any cortical layer, as increased pERK was found uniformly across cortical layers (layer II-III: t (1,22) = 2.35, P < 0.05; layer V-VI: t (1,22) = 2.19, P < 0.05; Fig. 5 i,j) . Further analysis showed that pERK immunoreactivity localized predominantly to calcium/calmodulin kinase II (CaMKII)-expressing pyramidal cells, but not to GAD67-expressing GABAergic cells nor to cells not labeled by either marker (Fig. 5k,l) . A parallel analysis of stressed female mice revealed equivalent localization patterns, with pERK immunoreactivity enriched in CaMKII-but not GAD67-expressing cells (Fig. 5g) .
Sex-specific control of synaptic activity by Dusp6 and Emx1
Given the role of ERK1/2 in regulating cellular activity 52 , our demonstration of increased pERK in pyramidal neurons suggests a potential impact on excitatory synaptic transmission in the vmPFC of depressed females and stressed mice. Thus, we assessed the impact of Dusp6 downregulation on the excitability of pyramidal neurons in this region of female and male mice (Fig. 6a) . Downregulation of Dusp6 in female vmPFC significantly increased the frequency of spontaneous excitatory postsynaptic currents (sEPSCs; F (2,151) = 6.31, P < 0.005; Fig. 6b,d ) without changing their amplitude (Fig. 6b,e) in infected (Dusp6-downregulated) compared to control GFP-expressing (P < 0.005) and uninfected (P < 0.01) pyramidal neurons. Notably, these effects were specific to females, as no change in sEPSC frequency (Fig. 6c,f) or amplitude (Fig. 6c,g ) was seen in male vmPFC.
We confirmed that these effects of Dusp6 downregulation were associated with elevated pERK. Cells infected by the Dusp6-downregulating HSV also showed elevated pERK ( Supplementary Fig. 8a,b) . Elevated pERK immunoreactivity was found predominantly in CaMKIIexpressing pyramidal neurons and not GAD67-expressing GABAergic neurons nor in cells not stained by either marker ( Supplementary  Fig. 8a,b,d ). Further investigation revealed that cells exhibiting elevated pERK following Dusp6 downregulation also coexpressed the vesicular glutamate transporter VGLUT1, confirming their identity as glutamatergic neurons (Supplementary Fig. 8c ). pERK immunoreactivity was found in the cell soma and dendrites ( Supplementary  Fig. 8a,c) . Notably, the changes induced by the viral downregulation of Dusp6 were found both in males (t (1,6) = 14.51, P < 0.0001; Supplementary Fig. 8e ) and females (t (1,6) = 8.23, P < 0.0005; Supplementary Fig. 8e ), consistent with equivalent downregulation of Dusp6 in the two sexes. Thus, this equivalent biochemical effect induces very different downstream physiological actions and behavioral sequelae in females versus males. We performed a similar assessment of the physiological impact of Emx1 overexpression in the vmPFC of male and female mice. Overexpression of Emx1 in male vmPFC significantly increased the frequency of sEPSCs (F (2,152) = 7.92, P < 0.005; Fig. 6i,l) without changing their amplitude (Fig. 6i,m) in infected (Emx1-overexpressing) compared to GFP-expressing (P < 0.005) and uninfected (P < 0.0001) pyramidal neurons. These effects were specific to males, as no change in sEPSC frequency (Fig. 6h,j) or amplitude (Fig. 6h,k) was seen in female vmPFC.
Dusp6 and Emx1 control the transcriptional organization of their respective gene modules We next assessed how the downregulation of Dusp6 would change gene expression profiles as compared to the effect of CVS in females. We found that Dusp6 downregulation plus subthreshold stress (Supplementary Fig. 9a,b) reproduced a large proportion of the transcriptional changes induced by 21 d of stress in female mice. Indeed, using RRHO analysis, we found a significant overlap for genes up-or downregulated in common in the vmPFC after Dusp6 downregulation and 21 d of stress (FET P < 1.0 × 10 −164 ; Supplementary Fig. 9c) . Analysis of the gene ontology pathways upregulated in common revealed several terms related to ERK signaling, such as Ras protein signaling, phosphorylation metabolism and ATPase coupled activity (Supplementary Fig. 9d ). Furthermore, 36% (n = 781, P = 1.15 × 10 −68 ; odd ratio = 2.37) of the genes differentially expressed in female vmPFC after 21 d of stress were also differentially expressed in the female vmPFC after Dusp6 downregulation followed by 3 d of stress (Supplementary Fig. 9e ). In addition, we compared these transcriptional changes against our human gene networks and found that 11 of 18 genes comprising the Gray26 module were up-or downregulated by Dusp6 downregulation plus subthreshold stress. In contrast to these findings in females with Dusp6 downregulation, we found modest overlap between genes up-or downregulated in common in the vmPFC following Emx1 overexpression and 21 d of stress in males ( Supplementary Fig. 9f-h ). Only 14% (n = 195; P = 1.97 × 10 −3 , odd ratio = 1.27) of genes differentially expressed following 21 d of stress in males were also differentially expressed following Emx1 overexpression (Supplementary Fig. 9i ). We also found that 21 hub genes within the Peru module (out of 43 total hub genes) were up-or downregulated by Emx1 overexpression followed by 6 d of stress (Supplementary Fig. 9g) . Thus, while Emx1 overexpression in the vmPFC increases stress susceptibility and neuronal excitability in males, its ability to reproduce the transcriptional alterations induced by prolonged stress in males appears limited, likely underlying a more subtle role of this gene.
DISCUSSION
The heterogeneity of depressive disorders is one of the main impediments to better understanding them and developing improved treatments 53 .
b c r e s o u r c e
Here, leveraging the intrinsic properties of gene coexpression network analysis, we highlight the fundamental differences in stress responses in males versus females and provide a framework for better understanding the molecular basis of the sexual dimorphism characterizing MDD. Our findings suggest that MDD in males and females arises in part from the actions of similar gene modules sharing cellular and biological specificity, but organized and expressed differently across brain regions in the two sexes (Supplementary Fig. 10 ).
Alterations in this precise transcriptional structure may then interfere with the coordinated activity of several brain regions in males and females and consequently disrupt the strategies normally used for coping with stress. Our findings provide compelling evidence that DUSP6 acts as a key hub gene, which by definition is more likely to be of functional importance 48 , for MDD in females. Dusp6 downregulation increased stress susceptibility by increasing the excitability of a population of glutamatergic pyramidal neurons in vmPFC via the activation of ERK signaling in females specifically. This is in contrast with the results of a series of previous functional and molecular studies in rodents [54] [55] [56] and postmortem human brain 56 . However, our study was conducted in the vmPFC, the functional homolog of BA25, while most previous studies focused on different cortical regions or on NAc. Furthermore, increased BA25 baseline activity has been observed in patients with treatment-resistant MDD compared to controls, which is reduced to control levels after 3-6 weeks of treatment with deep brain stimulation 57 . Thus, globally our results are consistent with previous work implicating ERK signaling in MDD, although further work is needed to understand why Dusp6-dependent enhancement of ERK signaling in female vmPFC induces depressionrelated abnormalities while equivalent enhancement in male vmPFC is without discernable effect.
Although our results suggest that the expression of stress susceptibility in males and females is mediated by mostly different genes and partly different pathways, such differences can converge onto some common physiological outputs (Supplementary Fig. 10 ). Indeed, both Dusp6 downregulation and Emx1 overexpression resulted in higher frequencies of sEPSCs in vmPFC pyramidal neurons in females and males, respectively. However, the transcriptional overlap between Emx1-overexpressing male mice and 21 d CVS males was limited, suggesting a more subtle role in mediating stress susceptibility. Being highly expressed in early cortical developmental phases, Emx1 is believed to be involved in early functional circuitry development 51, 58 . As such, its acute overexpression during adulthood may be sufficient to activate critical pathways involved in synaptic plasticity but may require longer incubation periods before reproducing to a significant degree the transcriptional pattern induced by 21 d of stress. Furthermore, as a transcription factor, its binding to DNA might require precise a chromatin structure that may occur only after prolonged periods of stress.
Previous attempts to decipher the genetic bases of MDD met with limited success, although more recent studies have proven more successful 41, 59 . Notably, several gene targets identified in these studies are found within the top gene networks in our study and highlight the heterogeneity of the disorder, not only from a clinical but also from a molecular and mechanistic point of view. While these studies reported no MDD-associated genetic sex difference 41, 59 , we found these gene targets within highly sexually dimorphic gene networks, suggesting that the sexual dimorphism defining MDD may be taking place at the transcriptional rather than at the genetic levels. More work is required to understand this complex relationship, as well as the basis of the sexual dimorphism observed in human MDD, part of which may rely on gonadal hormones and chromosomally based sex differences.
To conclude, by defining the transcriptional signatures of males and females with MDD, we provided solid evidence uncovering the molecular and cellular mechanisms underlying sex-specific stress susceptibility. This study represents a robust resource for the study of sex differences in mood disorders and the identification of molecular pathways which may be significantly involved in mediating the effect of stress in males and females. Future investigations should extend this work to assess the potential associations between brain and blood gene networks, with the promise that the latter might reveal gene signatures related to diagnostic subtypes or treatment responses. Nevertheless, by showing here that MDD in males and females originates from the alterations of mostly distinct genes converging on partly similar functional pathways, we provide a strong basis on which to build the foundation for a better understanding of the molecular mechanisms taking place in the brain of males and females with MDD, insights which can be used to develop treatment strategies targeted selectively to the two sexes.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Table 1 ; see also Cohort 1 metadata, http://neuroscience.mssm.edu/nestler/contecenter/listchromatingenedatabase.html). Inclusion criteria for both cases and controls were the following: the subject had to be European ancestry and of French-Canadian origin and the subject had to die suddenly, without prolonged agonal state. Forty-eight subjects (26 MDD: 13 males, 13 females; 22 controls (CTRL): 13 males, 9 females) were recruited for this study. Tissue from six brain regions-orbitofrontal cortex (OFC; BA11), dorsolateral PFC (BA8/9; dlPFC), cingulate gyrus 25 (BA25; cg25; vmPFC), anterior insula (aINS), nucleus accumbens (NAc) and ventral subiculum (vSUB)-was carefully dissected at 4 °C after having been flash-frozen in isopentane at −80 °C. An additional group of 32 male samples (15 MDD and 17 CTRL) from The University of Texas Southwestern Medical Center brain bank was used for the validation of male DEGs. A third cohort composed of 18 female samples (6 MDD and 12 CTRL) from the UT Southwestern brain bank was used for the validation of female DEGs. Sociodemographic and clinical information for the second and third cohorts is listed in Supplementary Tables 5 and 6, respectively. Tissue dissection was performed by histopathologists using reference neuroanatomical maps 61, 62 . The human study was approved by the research ethics boards of McGill University and UT Southwestern. Written informed consent was obtained from all participants.
Information concerning psychiatric history and socio-demographics was obtained by way of psychological autopsies performed by trained clinicians with the informants best acquainted with the deceased as described elsewhere, which has been shown to yield highly valid information 63, 64 . Both cases and controls were characterized by the same psychological autopsy methods, therefore avoiding the occurrence of systematic biases. Diagnoses were obtained using DSM-IV 65 criteria by means of SCID-I interviews 66 adapted for psychological autopsies. We should note that the discovery cohort contained a relatively high proportion of suicide completers, which raises the question of whether this might confound our findings. First, the occurrence of suicide among a small number of control subjects likely is not indicative of a depressive disorder since the psychological autopsies obtained provided a thorough and reliable assessment of clinical and subclinical manifestations 63 . Second, the fact that a large majority of gene targets identified in our discovery cohort were validated in replication cohorts with far fewer suicide cases argues against suicide as a critical factor. Finally, our principal component analysis showed no significant effect of the "cause of death" variable on overall variance in the gene expression data.
Animal experiments. Animals. Eight-week-old C57BL/6J male or female mice (Jackson Laboratory) were used. All mice were habituated to the animal facility for 1 week before experimental manipulations and were maintained at 23-25 °C on a 12 h light/dark cycle (lights on from 7:00 a.m.) with ad libitum access to food and water. Experiments were conducted in accordance with guidelines of the Society for Neuroscience and the Institutional Animal Care and Use Committee (IACUC) at Mount Sinai.
Chronic variable stress (CVS). CVS, modified from LaPlant et al. 67 and Hodes et al. 39 , consists of three different stressors repeated over a period of 21 d in both male and female mice. Stressors are alternated during the 21 d to prevent stress habituation. Stressors were administered in the following order: 100 random mild foot shocks at 0.45 mA for 1 h (10 mice to a chamber), a tail suspension stress for 1 h, and a restraint stress in which mice are placed inside a 50 mL Falcon tube for 1 h within the home cage. The three stressors were then repeated for the next 21 d in the same order. Samples included in these experiments are described in the statistical section below. Mice were housed five per cage over the period of stress and rehoused one mouse per cage before behavioral assessment. For both males and females, unstressed group-housed mice were used as controls; control mice were also rehoused one per cage before behavioral experiments. Statistical outliers were detected and removed based on Grubbs test criteria. The impact of stress on males and females was assessed using a generalized linear model with stress (stress or control) and sex (male or female) as main factors. Significance was fixed at P < 0.05 two-sided. A second cohort of mice (20 males: 10 stressed, 10 control; 20 females: 10 stressed, 10 control) were subjected in parallel to the same stress protocol but were killed on the day after the last stressor to collect vmPFC and NAc tissue for RNA-seq using 12-and 14-gauge punches, respectively. The same protocol was applied to generate tissue for protein and immunohistochemistry (IHC) experiments.
Splash test. Behavioral testing was based on a published protocol 39, 67 . The test was performed under an incandescent red light bulb (230 V, 15 W). Mice were habituated to the room for 1 h before testing. Mice were sprayed on the back with a 10% sucrose solution three times and then placed into an empty housing cage. Behavior was recorded for 5 min via videotape. The total amount of time grooming over the 5 min period was hand-scored by an observer blind to experimental conditions.
Novelty-suppressed feeding (NSF).
Behavioral testing was adapted from a published protocol 39, 67 . Mice were food restricted overnight before testing. On the day of testing, mice habituated to the testing room for 1 h. Under red light conditions, mice were then placed into a plastic box 50 × 50 × 20 cm with bedding. A single pellet of food was placed in the center of the box. Mice were placed in the corner of the box and the latency to eat was scored up to 10 min during testing. Mice were then immediately transferred to their home cage in standard lighting conditions and the latency to eat was recorded.
Sucrose preference. Behavioral testing was conducted according to previously published protocols 39, 67 . Immediately after the splash test, mice were separated and individually housed. They were given two bottles filled with water for a 24-h habituation period. The following day, immediately after NSF testing, one of the two 50-ml bottles was replaced with a 2% sucrose bottle for 24 h. The two bottles were then weighed and position was switched for an additional 24 h. The total duration of the test was 48 h. Sucrose was calculated by determining the percentage of total sucrose consumption divided by total liquid consumption (sucrose + water).
Forced swim test (FST).
Behavioral testing was conducted according to previously published protocols 39, 67 . Twenty-four hours after the NSF test, animals were placed in the test room for 1 h before behavioral testing. Mice were tested in a 4 L glass beaker containing 2.5 L of water at 25 ± 1 °C for 6 min. Behavior was videotaped and hand scored, by an observer blind to experimental conditions, using a 5-s sampling method for percentage of time spent immobile.
Open field test (OFT).
Mice were acclimated to the testing facility for 1 h before testing. Under red light conditions, mice were then placed into a plastic box 50 × 50 × 20 cm with bedding and time spent in the periphery and center was calculated using an automated system (Noldus Ethovision; Noldus Interactive Technologies).
Elevated plus maze (EPM).
Mice were acclimated to the testing facility for 1 h before testing. Animals were placed in the EPM under red light conditions for 5 min. Each arm of the maze measured 12 × 50 cm. The black Plexiglas crossshaped maze consisted of two open arms with no walls and two closed arms (40 cm high walls) and was on a pedestal 1 m above floor level. Behavior was tracked using an automated system (Noldus Ethovision; Noldus Interactive Technologies). Behavior was measured as total time spent in combined open arms and total time in combined closed arms.
Subthreshold chronic variable stress. A subthreshold version of CVS was used to study stress susceptibility; this duration of stress by itself is insufficient to induce stress-related behavioral abnormalities in males and females, but when combined with certain virally mediated modifications of gene expression can yield enhanced stress susceptibility 39 . In males, the same stressors described above were repeated over a period of 6 d, while in females stressors were repeated for 3 d after surgery. On day 7 in males and 4 in females, behavior was assessed in the NSF, sucrose preference, OFT, FST and EPM tests as described above. Mice were killed the following day. To examine potential antidepressant-like effects of Dusp6 overexpression, we used a 6-d course of CVS, which is sufficient to induce maximal behavioral abnormalities in female mice 39 . Females were injected intra-vmPFC with viral vectors and then subjected to 6 d of the same stressors described above; on day 7, behavior was assessed in the NSF, sucrose preference and grooming tests. Mice were killed the following day. Viral constructs. Knockdown (KD) constructs designed to target Dusp6 mRNA were cloned using BLOCK-iT Pol II miR RNAi kit (Invitrogen). Briefly, four artificial miRNA oligonucleotides were designed using Invitrogen's RNAi Designer (http://www.invitrogen.com/rnai/) to KD Dusp6 and cloned into pcDNA6.2-GW. Mouse neuroblastoma (N2a) cells were transfected using Lipofectamine 2000 (Invitrogen) with the different plasmids designed to target Dusp6 or with a lacZ plasmid as control. The level of Dusp6 mRNA KD was assessed using qRT-PCR. The miRNA causing the most efficient downregulation was Gatewaycloned (Invitrogen) into the p1005+ HSV (herpes simplex virus) vector. For overexpression, Dusp6 and Emx1 coding regions were excised from Dusp6 (Origene cat. no. MR222688) and Emx1 (Origene cat. no. RC208006) expression plasmids and cloned into the p1005+ HSV vector.
Stereotaxic surgeries and viral-mediated gene manipulations. Emx1 and Dusp6
overexpression and Dusp6 KD in the vmPFC was achieved by injecting HSV vectors expressing Emx1, Dusp6 or an siRNA targeting Dusp6, as well as green fluorescent protein (GFP). HSV-GFP was used as a control. Briefly, mice were anesthetized using a mixture of ketamine (10 mg/kg) and xylazine (1 mg/kg), and the following stereotaxic coordinates were used for viral delivery: +1.8 mm (anterior/posterior), +0.8 (lateral), −2.75 (dorsal/ventral) at an angle of 15° from the midline (relative to bregma). A total of 0.5 µl of HSV solution was delivered bilaterally over a 5 min period (0.1 µl/min), followed by 5 min of rest.
The effect of Dusp6 KD and Emx1 overexpression was initially assessed on the samples described in the statistical section below. Male and female mice were tested 7 and 4 d after surgery, respectively, and viral injection sites were confirmed using standard histological methods. Statistical outliers were detected and removed based on Grubbs test criteria. For every tested gene, the impact of stress on males and females was assessed using a generalized linear model with stress (stress or control) and virus (tested gene or GFP control) as main factors. Significance was fixed at P < 0.05 with two-sided Tukey post hoc tests.
The same protocol was used to generate tissue for the IHC validation experiments and RNA-seq experiments. Samples used for IHC and RNA-seq experiments are described in the statistical section below. For IHC validation of virally mediated Dusp6 downregulation, mice were stressed through the same protocol and analyzed the day after the last stressor. The same tissue was used for IHC co-staining experiments.
The effect of Dusp6 overexpression was assessed with 6 d of subthreshold CVS on the samples described in the statistical section below. Female mice were tested 7 d after surgery and viral injection sites were confirmed using standard histological methods. Statistical outliers were detected and removed based on Grubbs test criteria. For every tested gene, the impact of stress on females was assessed using a generalized linear model with stress (stress or control) and virus (Dusp6 or GFP control) as main factors with Tukey post hoc tests. Significance was fixed at P < 0.05 two-sided with Tukey post hoc tests.
Immunohistochemistry. Mice were anesthetized with a mixture of ketamine (10 mg/kg) and xylazine (1 mg/kg) and perfused with cold 4% paraformaldehyde in PBS. Brains were removed, postfixed and cryoprotected in PBS + 15% sucrose for 2-3 h, followed by immersion in PBS + 30% sucrose for 24 h, and then sectioned coronally (35 µm) on a microtome. Free-floating sections were permeabilized with blocking buffer (PBS + 3% normal donkey serum, 0.3% Triton X-100) for 2 h and then incubated with primary antibodies (GAD67, Santa Cruz (sc-7512), 1:250; CaMKII, Santa Cruz (sc-5306), 1:400; phospho-ERK1/2 (pERK), Cell Signaling (4370s), 1:200; VGlut1, Millipore (AB5905), 1:10,000) overnight at 4 °C. Slices were then washed four times for 15 min each with PBS, incubated with corresponding secondary antibodies (donkey antimouse Cy3 1:400 (715-165-150), donkey anti-rabbit Cy5 1:400 (711-175-152), or donkey anti-goat Cy2 1:400 (705-175-147), Jackson ImmunoResearch) for 2 h, washed four times for 15 min each with PBS and mounted on microscope slides, followed by counterstaining with DAPI, and coverslipped for confocal imaging. Sections were imaged using a Zeiss LSM 780 microscope. For analysis of GAD67 and GFP colocalization with pERK, 5-µm z-stacks were taken at ×63 magnification in the vmPFC of male or female mice. Sample size is described in the statistical section below. Cell body mean optical density (O.D.) was measured for pERK-positive cells in each channel (GAD67-Cy5, pERK-Cy3, GFP) and compared to mean O.D. values of a reference positive cell. pERK immunohistochemistry analysis was also performed on orbitofrontal cortex (BA11) of postmortem human brain (n = 4 per group). BA11 was used because BA25 was not available for IHC and because the module differential expression enrichment pattern in females was equivalent for BA25 and BA11. All tissue samples were fixed in 4% PFA for 3 weeks, then cryoprotected gradually in 10%, 20% and 30% sucrose in 0.1 M PBS and snap frozen in cold (−40 °C) 2-methylbutane. Non-serial sections (30 µm thick, 60 µm apart) were cut on a cryostat (Leica CM3050S) and mounted on SuperFrost Plus slides for pERK IHC. All slides were subjected to microwave antigen retrieval (Citra solution, BioGenex; 95 °C for 10 min), quenched free of endogenous peroxidases in 0.3% H 2 O 2 and then processed with the instructions from the ImmPRESS Excel staining kit (Vector Laboratories). Briefly, sections were blocked in normal horse serum before overnight incubation of pERK (Thr202/Tyr204) rabbit monoclonal antibody (1:200; Cell Signaling (4370s)). Primary antibody was detected by sequential incubation with goat anti-mouse IgG (Vector Labs (AI-9200)) and HRP-conjugated horse antigoat IgG (Vector Labs (PI-9500)). Diaminobenzidine chromogen was used to detect immunoperoxidase signal, and hematoxylin was used as the counterstain. Negative controls were performed by omitting primary antibody and by using primary antibody preincubated with pERK (Thr202/Tyr204) blocking peptide (Cell Signaling); the signal was fully absent with both approaches. For double staining, primary antibodies were simultaneously incubated with tissue sections: pERK 1:50 (Cell Signaling, 4370s)/CaMKII 1:400 (Santa Cruz, sc-5306), pERK 1:50/GAD67 1:800 (Santa Cruz, sc-7512)). Cy3-conjugated donkey anti-rabbit IgG (1:200; Jackson ImmunoResearch, 711-165-152) and Cy2-conjugated donkey antimouse IgG (1:200; 715-225-150) were used to detect primary antibodies.
Stereology. All slides were coded before blinding, and the observer was blinded to subgroups. Unbiased estimates for pERK + and pERK − cells in each group were obtained using stereology on an Olympus BX51 System Microscope (Optronics, Goleta, California, USA). Cell counts were collected using the Optical Fractionator Probe within Stereo Investigator software (MBF Bioscience, MicroBrightField, Inc., Williston, Vietnam, USA). The region of interest (ROI) in all cortical layers and cortical sublayers (II/III and V/VI layers) was identified with the help of hematoxylin counterstain. Cell counting was performed using a 40×, 0.63 NA lens. pERK + cells were identified as the cells containing a brown reaction product of sufficient intensity within the whole cell body, and pERK − cells were identified as the cells only containing a blue reaction of hematoxylin within the nucleus; cells that related to blood vessels were excluded from counting. The optical dissector height was 15 µm. The area-sampling fraction was 1/20 for all layers and 1/12.5 for sublayer counting. Sample size is described in the statistical section below.
Western blotting. For human tissue, vmPFC from our initial RNA-seq cohort was combined with samples from our second and third cohorts. Human and animal sample sizes are described in the statistical section below. Tissue from human and mouse vmPFC was carefully dissected and sonicated in RIPA buffer (pH 7.4, plus protease and serine/threonine and tyrosine phosphatase inhibitors). The sonicates were centrifuged at 10,000g for 10 min at 4 °C and the supernatant was retained for protein analysis. Total protein content was measured with a DC protein assay. Samples (25 µg/lane) were mixed with reducing sample buffer containing SDS and DTT and were heated to 95 °C for 5 min. Samples were resolved by SDS-PAGE on precast Bio-Rad gels and transferred to PVDF membranes. Membranes were blocked in 5% BSA in TBSTween (TBST) for 1 h and incubated at 4 °C overnight with primary antibodies (pERK, Cell Signaling (4370s), 1:1,000; ERK, Cell Signaling (4696s), 1:1,000; actin, MP Biomedicals (691002), 1:20,000) diluted in 5% bovine serum albumin in TBST. After thorough washing, membranes were incubated with peroxidaseconjugated secondary antibodies (Vector Labs, PI-9500) in blocking solution at room temperature for 2 h, washed thoroughly and developed using chemiluminescent substrate (Thermo Scientific). Quantification of protein expressed in each lane was determined by densitometry using Image J. pERK and total ERK1/2 expression levels were normalized to actin. Variation in pERK and total ERK1/2 levels, in both mice and humans, was assessed by means of independent sample t-test comparing male MDD with male CTRL or female MDD and female CTRL. t-tests in mice were two-sided and one-sided in humans. Significance was fixed at P < 0.05.
In vitro electrophysiology. Recordings were restricted to pyramidal neurons with large, tear-drop-shaped somas and conspicuous apical dendrites. Interneurons, which exhibited small rounded somas and a lack of the apical process, were avoided. Besides the morphological criteria, the action potential firing patterns were also used to differentiate between pyramidal neurons and interneurons 68 . Mice were injected with an HSV expressing miRNA targeting Dusp6, expressing Emx1 or expressing GFP alone 2 d before electrophysiological recordings. Sample size is described in the statistical section below. Virally infected neurons were distinguished from uninfected neurons by their GFP signals under epifluorescence microscopy. Spontaneous excitatory postsynaptic currents (sEPSCs) of pyramidal neurons were recorded for 3 min in voltageclamp mode, with a K + -based internal solution (in mM: 130 potassium methanesulfonate, 10 KCl, 10 HEPES, 0.4 EGTA, 2.0 MgCl 2 , 3 Mg-ATP, 0.5 Na 3 -GTP, 7.5 phosphocreatine, pH 7.4; 285 mOsm). The data (frequency and amplitude of sEPSCs) were analyzed with Minianalysis Program (Synaptosoft Inc.). For Dusp6 KD and Emx1 overexpression, the sex-specific impact of Dusp6 and Emx1 on pyramidal neuron excitability was assessed using a generalized linear model with sex (male or female) and virus (Dusp6 miRNA-infected, GFP-infected or uninfected) as main factors with two-sided Tukey post hoc tests. Significance was fixed at P < 0.05.
RNA sequencing and bioinformatics. RNA from human and mouse brain samples was extracted using an RNeasy micro kit using Trizol, followed by DNase 1 treatment, as described by the manufacturer (Qiagen). RNA integrity number (RIN) and concentration were assessed using a Bioanalyzer (Agilent). External RNA Controls Consortium (ERCC) spike-in controls were added at a concentration of 1:1,000 to every RNA sample. Libraries were constructed using the ScriptSeq Complete Gold Kit (Epicentre, Illumina) preceded by ribosomal RNA depletion starting with 1 µg of RNA in humans and 100 ng of vmPFC RNA and 300 ng of NAc RNA in mice. vmPFC samples from virally infected mice were processed the same way using 300 ng of RNA. Samples were barcoded for multiplexing and sequenced at 50 bp paired-end on Illumina HiSeq2500. Samples were pooled eight per lane and sequenced twice at a depth of 50 million reads per sample.
Data processing and differential gene expression analysis. FASTQ and FASTXToolkit were used to examine the sequencing quality and trim reads. Paired-end reads for the human data were aligned to the GENCODE 2014 version of the human genome while the mouse data were mapped to the GENCODE vM2 mm10 annotation using TopHat. Both data sets were mapped using the comprehensive gene annotation on the reference chromosome only. In humans, all samples passed quality control (QC) with the exception of 6 samples (1 female MDD in OFC, 1 male control and 1 male MDD in vmPFC, 1 female control in dlPFC, 1 male control in aINS and 1 female MDD in vSUB) that had excessively high levels of rRNA or extremely low mapped read percentage and were thus removed from the analysis. In mice, 4 samples were removed (1 stressed male and 2 stressed females in the vmPFC, 1 stressed female in the NAc) due to excessively high levels of rRNA or extremely low mapped read percentage. Using the same criteria in the virally infected mouse RNA-seq samples, 1 sample was removed from the female Dusp6 KD and none from the GFP female mice while no sample was removed from the male Emx1 and 1 from the male GFPexpressing mice. ERCC spike-in controls were used to assess the quality of each sequencing run and to insure replicability of runs 1 and 2 for every sample as previously described 69 . Reads from runs 1 and 2 for every sample were merged and counted using HTSeq. A gene was considered the union of all its exons in any known isoforms, based on GENCODE annotation. Any reads that fell in multiple genes were excluded from the analysis. Threshold for filtering out genes expressed at low levels was set to >5 reads in at least 80% of the samples as previously described 70 .
Human and mouse samples were processed separately. Differentially expressed genes (DEGs) between groups of samples were determined in several stages to ensure both statistical significance and biological relevance. In the first stage, linear models implemented in the limma package 71 of Bioconductor were used to compute the variance of gene expression across all groups. Gene expression was transformed and normalized using voom in the limma package. In humans, models were adjusted for age, RIN, alcohol abuse and medication status. Among the extensive information collected from the individuals in this study, these variables were selected for adjustment based on a combination of domain knowledge and variance analysis of the RNA-seq data. Eigen-R2 (ref. 72 ) was used to estimate the amount of variance in RNA-seq data explained by each variable. The estimate for each variable is similar to taking the average of the correlations between the variable and the expression values for each gene. Correlation averages are vulnerable to technical artifacts such as stochastic noise for genes with little or no expression; Eigen-R2 uses principal component analysis to reduce the contributions of these and other problematic genes. Using Eigen-R2 we found evidence that phenotype (PC4: P < 0.01), sex (PC3: P < 1.0 × 10 −4 ) and brain region (PC1: P < 5.0 × 10 −36 ) explained the most variance. Furthermore, we used the RUVg module from the RUV-seq package 73 to evaluate potential batch effects and technical variability of our RNA-seq data using the spike-in findings and extracted the top three unknown covariates. We then performed linear regression using the top three unknown covariates as predictors and the top ten principal components (PCs; from variance-transformed data) as response variables (Supplementary Table 22) . Using the orthogonality property of the PCs, we also calculated weighted sums of the variance explained by the top three unknown covariates and found them to account for 8%, 6% and 2%, respectively of the total variance. This analysis confirmed the absence of other variables with appreciable effects in our data sets.
DEGs were assessed through a generalized linear model implemented in limma, with phenotype (MDD versus CTRL) and sex (male and female) as main factors for every brain region. Our analyses were adjusted for age (PC2: P < 0.01), RIN (PC1: P < 1.0 × 10 −3 ) and alcohol abuse (PC2: P < 0.05) because these contributed to the variance according to the Eigen-R2 analyses, and we chose to adjust for medication status because medication is well known to change gene expression in the brain 46 . Overall, our model allowed us to generate a comprehensive evaluation of gene expression changes in males and females with MDD relative to controls, while controlling for the effects of major covariates and considering baseline differences in gene expression between males and females. An individual gene was called differentially expressed if the P-value of its t-statistic was at most 0.05. The exact same procedure was followed for the CVS mouse data analysis with phenotype (stress versus CTRL) and sex (male and female) as main factors and for the virally infected mice with phenotype (stress versus CTRL) and virus (Emx1 or Dusp6 KD versus GFP) as main factors. For the latter, male and female mice were analyzed separately given the difference in stress protocol used. RIN was the only factor we accounted for in our statistical analysis of our different mouse cohorts.
We also analyzed an external, publicly available data set: microarray data from 105 samples were downloaded from GEO (GSE53987) and were preprocessed and normalized using the rma function of the Affy Bioconductor package 74 . The limma Bioconductor package was then used to analyze the gene expression data, where age, PMI, pH and RIN were included as covariates in the linear model to test for differential gene expression (Supplementary Table 23 ).
The rank-rank hypergeometric overlap (RRHO) test 75, 76 was used to evaluate degree of overlap in gene signatures across brain regions in males and in females with MDD separately, as well as comparing males and females for every brain region. RRHO analysis was also used to assess the overlap between virally infected and CVS mice. Only genes found across all brain regions in both males and females with and without MDD (intersection) were used in this analysis. A one-sided version of the test only looking for overenrichment was used. RRHO difference maps were produced by calculating for each pixel the normal approximation of difference in log odds ratio and standard error of overlap with expression data in the intersection list. This z score was then converted to a P-value and corrected for multiple comparisons across pixels. For display, the P-value was multiplied by the sign of the effect to show both stronger and weaker matching between in vitro systems. Sex-specific regional overlap was further refined using two-sided Fisher's exact tests on genes across brain regions that were significantly differentially expressed (P < 0.05) in males and in females.
Comparisons between human and mouse transcriptional profiles were performed using the human and mouse orthologs, which we gathered using the Biomart package in R. The interspecies statistical overlap in the vmPFC and NAc for males and females was quantified using Fisher's exact tests with significance set at P < 0.05. Background was restricted to genes with known orthologs between human and mouse (according to biomaRt) and expressed at >5 reads in at least 80% of the samples (for both humans and mice). Interspecies assessment of gene ontology (GO) terms overlap was performed using an in-house R script. GO terms from both species being enriched for genes differentially expressed (P < 0.05) after multiple testing correction were first identified in the vmPFC and NAc. Only terms being significantly enriched after multiple testing correction from both species were considered overlapping.
NanoString assay. RNA from the vmPFC of all three human brain cohorts was processed through the NanoString-n-Counter system (Life Science). Up to 125 ng of RNA was submitted to the qPCR CORE at Mount Sinai for analysis. The code set was designed by the company to have unique sequences. We included a set of 3 male and 3 female control genes identified using our RNA-seq data as genes showing no difference in cases versus controls in both males and females (FC ±0; P = 0.99). For the original discovery (RNA-seq) cohort, normalization of NanoString read counts was performed using these control genes. Normalization of the replication cohorts was accomplished using NormaGene. No outliers were removed. Data were analyzed using one-sided independent samples t-test with significance set a P < 0.05. Experiments were performed three times.
Gene coexpression network analysis. We employed weighted gene coexpression network analysis (WGCNA) 47, 48 to identify coexpressed gene modules using RNA-seq expression data that were first normalized by conditional quantile normalization and corrected for the following covariates: age, pH, PMI, RIN, alcohol abuse, medication status and cause of death (Supplementary Table 1) . We constructed multi-tissue coexpression networks that simultaneously captured the intra-and inter-tissue gene-gene interactions between the MDD and normal states in both males and females. These networks can be characterized only when multiple tissues are monitored in a population of individuals covering all tissues analyzed (i.e., aINS, OFC, vmPFC, dlPFC, NAc, vSUB).
The weighted network analysis began with a matrix of the Pearson correlations between all gene pairs; we then converted the correlation matrix into an unsigned adjacency matrix using a power function, so that the resulting adjacency matrix-i.e., the weighted coexpression network-is approximately scale-free. To explore the modular structures of the coexpression network, the adjacency matrix was further transformed into a topological overlap matrix 47 . Because topological overlap between two genes reflects both their direct interaction and their indirect interactions through all other genes in the network, this approach helps create more cohesive and biologically more meaningful modules. To identify modules of highly co-regulated genes, we used average linkage hierarchical clustering to group genes based on the topological overlap of their connectivity, followed by a dynamic cut-tree algorithm to dynamically separate clustering dendrogram branches into gene modules. Each module was assigned a unique (and arbitrary) color identifier. Gene with the highest intramodular connectivity were considered hub genes (those connected with more members of the network). We used DAVID 77 v6.7 to assess the functional annotation (GO and KEGG) for each module, and we report FDR P-values and fold enrichment, as provided by DAVID.
To quantify differences in transcript network organization between MDD and control subjects in both males and females, as well as male MDD versus female MDD, we employed a modular differential connectivity (MDC) metric 44 . In brief, MDC represents the ratios of the connectivity of all gene pairs in a module from MDD subjects to that of the same gene pairs from control subjects. MDC is a continuous measure ranging from 0 to infinity. MDC > 1 indicates gain of connectivity or enhanced co-regulation between genes, whereas MDC < 1 indicates loss of connectivity or reduced co-regulation between genes. The statistical significance of the MDC metric was computed through the FDR procedure. The significance or FDR of the MDC statistic can be accessed by permuting the data underlying the two networks. We estimated FDR based both on shuffled samples (i.e., networks with nonrandom nodes but random connections) and shuffled gene labels (i.e., networks with random nodes but nonrandom connections) and then selected the larger value as the final FDR estimate.
To further identify key regulator (driver) genes of the modules identified by WGCNA, we applied the key driver analysis to the module-based unweighted coexpression networks derived from ARACNE (Algorithm for the Reconstruction of Accurate Cellular Networks) 78 . ARACNE was used first to identify significant interactions between genes in each module based on their mutual information and then remove indirect interactions through data processing inequality (DPI). For each ARACNE-derived unweighted network, we further identified the key regulators by examining the number of N-hop neighborhood nodes (NHNN) for each gene. For a given network, let µ be the numbers of N-hop downstream nodes and d be the out-degrees for all the genes. Genes with a number of NHNN greater than ū + σ(µ) were nominated as causal regulators. The regulators with degree above d d + 2s( ), where d denotes the number of downstream genes, become key causal regulators of a corresponding network module associated with MDD differential connectivity. This criterion identified genes with number of NHNNs significantly above the corresponding average value.
The assessment of module enrichment for genes expressed in specific cell types was performed using a published RNA-seq data set 79 . We focused our analysis on neuronal, astrocytic, myelinating oligodendrocytes, microglial and endothelial cell types. We first excluded all genes with no human orthologs and filtered out genes expressed at values below 1 FPKM. We then created sublists for genes expressed at least 5 times more in one cell type than in the average of the other cells type and used two-sided Fisher's exact tests to quantify the significance of the enrichment with significance fixed at P < 0.05.
We tested conservation of MDD modules between males and females with MDD by analyzing overlap of module members. Fisher's exact tests (two-sided) were used to quantify significant overlap and enrichment. The modules in male MDD that show significant overlap (FDR P < 0.05) and a fold change of greater than 15 with a module in female MDD were considered conserved, while the others were considered sex-specific. For enrichment analysis using gene sets from our differential expression analysis, two-sided Fisher's exact tests were performed. Fold enrichment and FDR corrected P-values are reported in all cases.
To assess how the modules in one reference sample group (for example, male MDD, male control, female MDD and female control) are preserved in another test sample group, we calculated network preservation statistics implemented in the WGCNA package 80 . Similarly to the MDC metric, network preservation statistics do not require independent module identification in a test group. However, network preservation statistics are different from the MDC metric in that they evaluate the preservation of connectivity patterns of the member genes and the distinctiveness of a module as a whole from the other modules. We report here the results of four module preservation statistics: median rank, Z density , Z connectivity and Z summary and their significance levels based on permutation tests. Z density and Z connectivity statistics are the standardized preservation statistic for density and connectivity, respectively. Z summary is the average of Z density and Z connectivity . The medianRank statistic is the average of the connectivity and density preservation ranks. Module preservation analysis was performed for the following four comparisons: (i) male MDD (reference data) versus male control (test data), (ii) male MDD (reference data) versus female MDD (test data), (iii) female MDD (reference data) versus female control (test data), and (iv) female MDD (reference data) versus male MDD (test data).
Statistical analyses. Sample size calculation was not performed. However, we justified every experiment sample size based on several previously published reports using similar or even smaller sample sizes and showing the power to detect significant statistical differences.
RNA-seq gene expression data for differential expression was normalized. For RNA-seq in humans, 48 subjects (26 MDD: 13 males, 13 females; 22 controls (CTRLs): 13 males, 9 females) were recruited. For RNA-seq on mouse tissue, 40 mice (20 males: 10 stressed, 10 control; 20 females: 10 stressed, 10 control) were used. For RNA-seq on virally mediated Dusp6 KD and Emx1 overexpression, 10 female and 10 male mice were used (5 Dusp6 stressed, 5 Emx1 stressed and 5 GFP stressed). RNA-seq and RRHO statistical methods are described above. Differential expression was not corrected for multiple testing. RRHO analysis was corrected using the Benjamini-Hochberg method. Bonferroni correction was used to correct for multiple testing when several Fisher's exact tests were performed simultaneously. NanoString analysis was performed on three cohorts. The first cohort was composed of the same samples used for RNA-seq. The second cohort was composed of 32 male samples (15 MDD and 17 CTRL) and a third cohort was composed of 18 female samples (6 MDD and 12 CTRL). Data were analyzed using one-sided independent samples t-test with significance set a P < 0.05. NanoString analysis was not corrected for multiple testing. The same samples used for differential expression analysis were included in the network analysis, the statistical methods for which are described above. Network analyses, including network construction, module differential connectivity, GO enrichment, module conservation and module differential expression enrichment were adjusted for multiple testing.
The impact of CVS on males and females was assessed using a generalized linear model with stress (stress or control) and sex (male or female) as main factors. Significance was fixed at P < 0.05 two-sided with Tukey post hoc tests. The following samples were included in the analysis of the different tests. Noveltysuppressed feeding: male CTRL n = 10, stressed males n = 12, female CTRL n = 10, stressed females n = 12; splash test: male CTRL n = 10, stressed males n = 12, female CTRL n = 10, stressed females n = 12; forced swim test: male CTRL n = 10, stressed males n = 12, female CTRL n = 10, stressed females n = 12; Sucrose preference: male CTRL n = 9, stressed males n = 11, female CTRL n = 9, stressed females n = 11.
Quantifications of Dusp6 KD, Dusp6 overexpression (OE) and Emx1 OE were assessed using independent sample t-tests (two-tailed). For Dusp6 KD, we used 9 mice (GFP n = 4; Dusp6 KD n = 5); for Dusp6 OE, 8 mice (GFP n = 5; Dusp6 OE n = 3) and Emx1 OE, 7 mice (GFP n = 4; Emx1 OE n = 3).The behavioral impact of Dusp6 KD, Dusp6 OE and Emx1 OE was assessed using a generalized linear model with stress (stress or control) and virus (tested gene or GFP control) as main factors. Significance was fixed at P < 0.05 with two-sided Tukey post hoc tests. For Dusp6 KD in females, in the NSF we used 29 mice (GFP CTRL n = 10; GFP stress n = 7; Dusp6 KD CTRL n = 7; Dusp6 KD stress n = 5) and in male 36 mice (GFP CTRL n = 9; GFP stress n = 9; Dusp6 KD CTRL n = 9; Dusp6 KD stress n = 9). For Dusp6 KD in females, in the sucrose preference test, we used 18 mice (GFP CTRL n = 4; GFP stress n = 4; Dusp6 KD CTRL n = 5; Dusp6 KD stress n = 5) and in males 35 mice (GFP CTRL n = 8; GFP stress n = 8; Dusp6 KD CTRL n = 9; Dusp6 KD stress n = 10). For Dusp6 OE in females, in the NSF we used 38 mice (GFP CTRL n = 10; GFP stress n = 10; Dusp6 OE CTRL n = 9; Dusp6 OE stress n = 9) and for the sucrose preference test, 33 mice (GFP CTRL n = 9; GFP stress n = 9; Dusp6 OE CTRL n = 7; Dusp6 OE stress n = 8). For Emx1 OE in males, in the NSF test, we used 37 mice (GFP CTRL n = 10; GFP stress n = 10; Emx1 OE CTRL n = 9; Emx1 OE stress n = 8) and in females, 36 mice (GFP CTRL n = 9; GFP stress n = 9; Emx1 OE CTRL n = 9; Emx1 OE stress n = 9). Experiments were performed once. pERK quantification in humans was performed on 63 human samples (male CTRL n = 16; male MDD n = 18; female CTRL n = 12; female MDD n = 17); total ERK, on 67 samples (male CTRL n = 17; male MDD n = 18; female CTRL n = 14; female MDD n = 18). To quantify pERK in mouse we used 43 samples (male CTRL n = 10; male stressed n = 12; female CTRL n = 9; female stressed n = 12) and for total ERK, we used 44 samples (male CTRL n = 10; male stressed n = 12; female CTRL n = 9; female stressed n = 12). Variation in pERK and total ERK1/2 levels, in both mice and humans, was assessed by means of an independent-sample t-test comparing male MDD/stress with male CTRL or female MDD/stress and female CTRL. t-tests were two-sided in mice and one-sided in humans. Significance was fixed at P < 0.05. Experiments were performed once.
For stereology in human postmortem brains, 4 female MDD and 4 female CTRL sample were used. Two sections were counted for all-layer and 3 sections were counted for sublayer statistics analysis. In mice, a total of 16 mice were used to quantify pERK (male CTRL n = 4; male stress n = 4; female CTRL n = 4; female stress n = 4). Two sections were counted for every animal. Significance was measured by means of independent sample t-tests (two-tailed) with P < 0.05. For total pERK density we used the data from a total of 30 images (male CTRL n = 8; male MDD n = 8; female CTRL n = 6; female MDD n = 8). For layer specificity, we used results from a total of 48 images (layer II/III and layer V/VI: female CTRL n = 12; female MDD n = 12). For pERK quantification in mice, we used results from 26 images (male CTRL n = 7; male stress n = 6; female CTRL n = 7; female stress n = 6). The impact of Dusp6 KD on pERK levels in CaMKII and GAD67 positive cells was quantified using the 1 picture per animal on 8 mice (GFP CTRL n = 4; Dusp6 KD n = 4) in both males and females. Experiments were performed once.
For electrophysiological recordings, 23 females (uninfected n = 10; GFP infected n = 4; Dusp6 KD infected n = 5 and Emx1 infected n = 4) and 22 males (uninfected n = 9; GFP-infected n = 5; Emx1-infected n = 4 and Dusp6 KDinfected n = 4) were used. Significance was assessed using a generalized linear model with sex (male or female) and virus (Dusp6 KD-infected, GFP-infected or uninfected) as main factors with two-sided Tukey post hoc tests. Significance was fixed at P < 0.05. For frequency and amplitude in Dusp6 KD, we used a total of 66 cells in females (uninfected n = 25; GFP-infected n = 17; Dusp6 KD n = 24) and 91 cells in males (uninfected n = 32; GFP infected n = 29; Dusp6 KD n = 30). For frequency and amplitude in Emx1 OE, in males we used 88 cells (uninfected n = 32; GFP infected n = 29; Emx1 OE n = 27) and in females 71 cells (uninfected n = 25; GFP infected n = 17; Emx1 OE n = 29). Experiments were performed once.
Detailed information on experimental design and reagents included in this study can be found in the Life Sciences Reporting Summary.
Code availability. Major network analysis tools are available as R packages. These include WGCNA, bnlearn (ARACNE implemented) and KDA (Key Driver Analysis) at CRAN (http://cran.r-project.org/) or on B.Z. 's laboratory webpage (http://research.mssm.edu/multiscalenetwork/). Data availability. Sequencing data and source files are available on NCBI GEO website (accession codes GSE102556). Cohort 1 metadata are available at http://neuroscience.mssm.edu/nestler/contecenter/listchromatingenedatabase.html. Any additional data supporting the findings of this study are available from the corresponding author upon reasonable request.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
For RNAseq, FASTQ and FASTX-toolkit were used to examine the sequencing quality and trim reads. Paired-end reads for the human data were aligned to the GENCODE 2014 version of the human genome while the mouse data were mapped to the GENCODE vM2 mm10 annotation using TopHat. Reads from run 1 and 2 for every sample were merged and counted using HTSeq. Eigen-R2 was used to estimate the amount of variance in RNAseq data explained by each variable. We used the RUVg module from the RUV-seq package to evaluate potential batch effects and technical variability of our RNAseq data. DEGs were assessed through a generalized linear model implemented in limma, with phenotype (MDD vs CTRL) and sex (male and female) as main factors for every brain region. We also analyzed an external, publicly available dataset from GEO (GSE53987). This data was pre-processed and normalized using the "rma" function of the Affy Bioconductor package. The Limma Bioconductor package was then used analyze the gene expression data in a linear model and test for differential gene expression. Rank Rank Hypergeometric Overlap (RRHO) test was used to evaluate degree of overlap in gene signatures across brain regions in males and in females with MDD separately as well as comparing males and females for every brain region. RRHO analysis was also used to assess the overlap between virally-infected and CVS mice. Gene network analysis was performed using the WGCNA package. Behavioral, NanoString, protein and IHC quantification, qPCR and electrophysiological data were all analyzed using Sigma from GraphPad.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There is no restriction on any of the material used in this study.
